Gender Gap in Leadership of Clinical Trials

Ithai Waldhorn; David Bomze; Irit Ben-Aharon; Shir Schlosser; Gal Markel; Ethan B Ludmir; Tomer Meirson

doi:10.1001/jamainternmed.2023.5104

Gender Gap in Leadership of Clinical Trials

JAMA Intern Med. 2023 Dec 1;183(12):1406-1408. doi: 10.1001/jamainternmed.2023.5104.

Authors

Ithai Waldhorn¹, David Bomze², Irit Ben-Aharon^{1

3}, Shir Schlosser^{2

4}, Gal Markel^{2

4

5}, Ethan B Ludmir^{6

7}, Tomer Meirson^{2

4

5}

Affiliations

¹ Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
² Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Rappaport Faculty of Medicine, Technion, Haifa, Israel.
⁴ Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
⁵ Samueli Integrative Cancer Pioneering Institute, Beilinson Hospital, Petah Tikva, Israel.
⁶ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.
⁷ Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.

No abstract available

Plain language summary

This cross-sectional study investigates representation of women as principal investigators of clinical trials by study phase, medical specialty, and representation of women trial participants.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Cross-Sectional Studies
Gender Equity*
Humans
Leadership
Physicians, Women*
Sex Factors